A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Public ClinicalTrials.gov record NCT06634589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2, Open-Label, Master Protocol Study of BTK-Degrader BGB-16673 in Combination With Other Agents in Patients With Relapsed or Refractory B-Cell Malignancies
Study identification
- NCT ID
- NCT06634589
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- BeOne Medicines
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Interventions
- BGB-16673 Drug
- Glofitamab Drug
- Mosunetuzumab Drug
- Obinutuzumab Drug
- Sonrotoclax Drug
- Zanubrutinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 26, 2024
- Primary completion
- Dec 1, 2028
- Completion
- Dec 1, 2029
- Last update posted
- May 6, 2026
2024 – 2029
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Phoenix | Phoenix | Arizona | 85054-4502 | Recruiting |
| University of Southern Californianorris Comprehensive | Los Angeles | California | 90033 | Recruiting |
| Mayo Clinic Jacksonville | Jacksonville | Florida | 32224-1865 | Recruiting |
| Moffitt Cancer Center | Tampa | Florida | 33612-9496 | Recruiting |
| The University of Kansas Cancer Center | Westwood | Kansas | 66205-2003 | Recruiting |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905-0001 | Recruiting |
| Washington University School of Medicine | St Louis | Missouri | 63110-1010 | Recruiting |
| Summit Medical Group | Florham Park | New Jersey | 07932-1049 | Recruiting |
| Icahn School of Medicine At Mount Sinai | New York | New York | 10029-6504 | Recruiting |
| Columbia University Medical Center | New York | New York | 10032 | Recruiting |
| Weill Cornell Medical College Newyork Presbyterian Hospital | New York | New York | 10065-4870 | Recruiting |
| Memorial Sloan Kettering Cancer Center Mskcc | New York | New York | 10065-6800 | Recruiting |
| University of Rochester | Rochester | New York | 14642-0001 | Recruiting |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111-2434 | Recruiting |
| The University of Texas Md Anderson Cancer Center | Houston | Texas | 77030-4009 | Recruiting |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112-5550 | Recruiting |
| University of Wisconsin | Madison | Wisconsin | 53792-0001 | Recruiting |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226-1222 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06634589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06634589 live on ClinicalTrials.gov.